Provided by Tiger Fintech (Singapore) Pte. Ltd.

ImmuCell

5.29
-0.0400-0.75%
Post-market: 5.290.00000.00%16:05 EDT
Volume:7.33K
Turnover:38.86K
Market Cap:47.52M
PE:-20.03
High:5.37
Open:5.34
Low:5.22
Close:5.33
Loading ...

The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell

Zacks
·
17 Apr

Top Stock Reports for Netflix, SAP & Shell

Zacks
·
17 Apr

Top Premarket Decliners

MT Newswires Live
·
11 Apr

ImmuCell Preliminary Q1 2025 Revenue Of $8.1M Up From $7.3M YoY; Reduced The Backlog Of Orders To $4M As Of March 31, 2025, From $4.4M As Of December 31, 2024

Benzinga
·
09 Apr

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

THOMSON REUTERS
·
09 Apr

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

GlobeNewswire
·
09 Apr

ImmuCell Appoints Timothy Fiori as New CFO

TIPRANKS
·
08 Apr

ImmuCell Names Timothy Fiori Finance Chief

Dow Jones
·
07 Apr

BRIEF-Immucell Hires Chief Financial Officer

Reuters
·
07 Apr

Immucell appoints Timothy Fiori as CFO

TIPRANKS
·
07 Apr

ImmuCell Corp - Hires Timothy C. Fiori as CFO

THOMSON REUTERS
·
07 Apr

ImmuCell Hires Chief Financial Officer

THOMSON REUTERS
·
07 Apr

Press Release: ImmuCell Hires Chief Financial Officer

Dow Jones
·
07 Apr

ImmuCell Starts Controlled Launch of Re-Tain for Infection in Dairy Cows

MT Newswires Live
·
03 Apr

Immucell initiates Investigational Product use of Re-Tain

TIPRANKS
·
03 Apr

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

GlobeNewswire
·
03 Apr

ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval for Re-Tain

Zacks
·
01 Mar

ImmuCell’s Earnings Call Highlights Robust Recovery

TIPRANKS
·
28 Feb

ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ...

GuruFocus.com
·
28 Feb

ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023)

Simply Wall St.
·
27 Feb